Brief: Jubilant Pharmova Says Completion Of USFDA Audit Of Contract Manufacturing Facility At Montreal
Nov 4 (Reuters) - Jubilant Pharmova Ltd JUBA.NS: COMPLETION OF USFDA AUDIT OF CONTRACT MANUFACTURING FACILITY AT MONTREAL USFDA HAS ISSUED 9 OBSERVATIONS PURSUANT TO COMPLETION OF AUDIT Source text: ID:nBSE879Sgn Further company coverage: JUBA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures